Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 8/20 | 0.56 |
| ▸ | PPARG | P37231 | 7/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ELANE | P08246 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5369095 | 1.00 | ADORA3 (0.60) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL5367947 | 1.00 | ADORA3 (0.60) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL11548490 | 0.87 | ADORA3 (0.61) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL5531801 | 0.86 | ADORA3 (0.47) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL8935672 | 0.86 | ADORA3 (0.60) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL13846158 | 0.86 | ADORA3 (0.60) | ADORA3PPARAPPARGOPRK1ALDH1A1 | |
| SCHEMBL8935669 | 0.86 | ADORA3 (0.60) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL1960387 | 0.85 | PPARG (0.62) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL28567745 | 0.85 | ESR1 (0.49) | ADORA3PPARAPPARGMEN1KMT2A | |
| SCHEMBL2106690 | 0.84 | ADORA3 (0.58) | ADORA3PPARAPPARGMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119923418-A | Methacrylic acid-containing composition, method for producing methacrylic acid ester, polymerizable composition, and method for producing methacrylic acid polymer | 三菱化学株式会社 | 2025-05-02 | — | — | CN | disclosed |
| US-7297715-B2 | PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders | MERCK & CO., INC. (US) | 2007-11-20 | — | — | US | disclosed |
| US-20060089404-A1 | Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders | MERCK SHARP & DOHME CORP. | 2006-04-27 | — | — | US | disclosed |
| EP-1107955-A2 | SUBSTITUIERTE 3-ARYL-PYRAZOLE ALS HERBIZIDE | Bayer Aktiengesellschaft (DE) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000012480-A2 | SUBSTITUTED 3-ARYL-PYRAZOLES AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-03-09 | — | — | WO | disclosed |
| EP-0105494-B1 | PROCESS FOR THE PREPARATION OF BENZOTHIAZOLYL PHENOXY-PROPIONIC-ACID DERIVATIVES | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-10 | — | — | EP | disclosed |
| EP-0062905-B1 | HETEROCYCLIC PHENYL ETHERS, PROCESS FOR THEIR PRODUCTION AND HERBICIDES CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-13 | — | — | EP | disclosed |
| EP-0105494-A2 | Process for the preparation of benzothiazolyl phenoxy-propionic-acid derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-04-18 | — | — | EP | disclosed |
| EP-0092112-A1 | Substituted phenoxy propionates | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1983-10-26 | — | — | EP | disclosed |
| EP-0062905-A1 | Heterocyclic phenyl ethers, process for their production and herbicides containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089404-A1 | Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders | PPARA, PPARG, PPARD | ADORA3 858/4885PPARA 1/4885PPARG 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.